Bayer AG Targets Return to Mid-Single-Digit Pharma Growth by 2027
Bayer AG has set a target to return its pharmaceuticals business to mid-single-digit sales growth by 2027, as the company […]
Bayer AG has set a target to return its pharmaceuticals business to mid-single-digit sales growth by 2027, as the company […]
The Government has decided to increase the validity of the World Health Organisations (WHO) good manufacturing practices (GMP) certification to […]
Biocon , India’s top-listed biotechnology company, expects to generate larger licensing income from pharmaceuticals business, its Chairman and Managing Director […]